Debargha Basuli, MD PhD Profile
Debargha Basuli, MD PhD

@DebarghaBasuli

Followers
238
Following
104
Media
1
Statuses
72

Nephrology Asst Professor @ECUHealth_IM I Transplant Nephrology @OHSUNephrology I

Joined November 2021
Don't wanna be here? Send us removal request.
@katiewiskar
Katie Wiskar
8 months
Confession: I LOVE hyponatremia 🤓 (I know, I know. What can I say, I'm a true internist!) HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary! Here are my top 10 hyponatremia tips and tricks - a 🧵
36
532
3K
@asnpublications
ASN Publications
9 months
Fluid overload occurs frequently in critically ill patients with AKI and is one of the indications for continuous kidney replacement therapy (CKRT). In this article, the authors state that available and emerging tools help predict and monitor volume status more actively and
2
54
141
@KIDNEYcon
KIDNEYcon
2 years
KIDNEYcon Registration is Open! April 6-8, 2024 Little Rock, AR https://t.co/WR0UUcbmUN Little Rock will experience the 2024 Total Solar Eclipse Discount room rates at the DoubleTree Hotel! @NephroRock @nephrosharma @nephrosingh @VelezNephHepato @kidney_boy
Tweet card summary image
kidneycon.org
Registration
2
16
34
@AlanYuNeph
Alan Yu🇭🇰
2 years
Re-reading excellent thread by @NephroMD. In Winzeler paper, UOsm>=500 is highly specific for non-responsiveness but v. insensitive 🤔How about: UOsm>500: don't bother with FR UOsm<300: FR should be first-line approach 300-500: Consider trial of FR ❓
0
6
21
@edgarvlermamd
Edgar V. Lerma 🇵🇭
2 years
DARE-ESKD 1: Pharmacokinetic Properties of SGLT2 inhibitor (SGLT2i) Dapagliflozin in Patients on Hemodialysis and Peritoneal Dialysis ca. 2023 from @CJASN #Nephpearls - Well tolerated - Slightly dialyzable - Non-accumulating pharmacokinetic properties https://t.co/cTRliEUxPG
2
143
334
@kidney_boy
Joel M. Topf, MD FACP
2 years
Looks like you can #Flozinate your dialysis patients! "In individuals with kidney failure on dialysis, dapagliflozin was well-tolerated, slightly dialyzable, and had non-accumulating pharmacokinetic properties" https://t.co/EUs4jsFEop
9
92
261
@KIReports
KIReports
3 years
✅IT OUT 👇 📢📢📢Tweetorial Alert (1/19)! What is the most common complication of routine outpatient hemodialysis (HD) treatments?
2
32
41
@GlomCon
GlomCon
3 years
Genomics in Glomerular Disease A GlomCon Pubs summary on genetic diagnoses of glomerular diseases by Dr. Benjamin Tan @NephBen Read more 👉🏻 https://t.co/HCnimnzIdv #GlomCon
1
12
20
@KitchingLab
Kitching Laboratory
3 years
Our article in @NatRevImmunol proposes that nephritis can be classified primarily according to cause, then by the lesion. This would improve management, education, understanding and research. Thanks to @hjanders_hans @PRomagnani and Prof Nelson Leung for a great collaboration.
@NatRevImmunol
Nature Rev Immunol
3 years
Glomerulonephritis: immunopathogenesis and immunotherapy https://t.co/NSia4DVsTh
2
22
60
@jeroendebaaij
Jeroen de Baaij
3 years
Sometimes people ask me to share some educational materials. Therefore, my Twitter guide to Gitelman Syndrome! 🫘🧬 The key literature will posted in this 🧵⬇️ 1/11
6
84
230
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
0
1
2
@ArgaizR
Eduardo R Argaiz
3 years
Ambulatory Hemodialysis Unit Rounds: Called to see a patient with hypotension: BP 76/40,🧠 OK, CRT 5 seconds 1st step ➡️🛑Ultrafiltration + 300 ml bolus. BP 90/60 Pt is a middle aged ♂️ w ESRD and T2DM 1/9 🧵
18
157
553
@drraviele
Raviele Antonio
3 years
📌 A very comprehensive stepwise ECG algorithm 👉 to predict site of origin of idiopathic VAs #ECG #CardioTwitter #EPeeps @adribaran @ECGTalk @DrFerminGarcia @DrJasonAndrade @DhirajGuptaBHRS @SeguraCardio @jvillacastin @smithECGBlog @AskDrShashank @ecgrhythms @iamritu @Hragy
15
271
740
@ArgaizR
Eduardo R Argaiz
3 years
#AKIConsultSeries:👨w T2DM➡️🏥 for fever, dysuria and CVA tenderness. On arrival: ⬇️BP, ⬆️Glucose, ⬆️AGMA. Dx UTI + DKA. Tx: Abx + Insulin Pump + 4 L Crystalloid + NE After resus, pt still oliguric, Cr 3.2. NE 0.7 ug/kg/min,🧠confused, BP 85/62, HR 123, 2L O2. CRT 4 sec 1/12
27
193
586
@ckd_ce
@CKD_ce
3 years
1) Welcome to this new #accredited #tweetorial on best practices for providing #interprofessional, multidisciplinary, and multimodal pharmacologic therapy for patients with #CKD-associated anemia #aCKD. #MedTwitter #FOAMed #nephtwitter @MedTweetorials
1
19
30
@kidney_boy
Joel M. Topf, MD FACP
3 years
sacubitril...any data in ESRD? #AskRenal
10
12
41
@ckd_ce
@CKD_ce
3 years
1) Welcome to a new #accredited #tweetorial on the latest advances in the management of #CKD in the setting of patients with and without #T2D--this time with a hot-off-the-presses update from #ASN22 #KIDNEYWEEK2022: eagerly-awaited results of the #EMPA_KIDNEY trial.
2
22
57
@goKDIGO
KDIGO
3 years
KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline. Read the Guideline: https://t.co/A6LdZbr3qg Read the Executive Summary: https://t.co/vnt32SGix3 Read the News Release: https://t.co/LMc8JRFyM2 #diabetes #CKD
6
332
645
@ArgaizR
Eduardo R Argaiz
3 years
🧵Complex #Hemodynamics in ESRD: Middle age pt ➡️ 🏥 for syncope HPI: Low BP during HD sessions. Does not achieve dry weight. Today she has had 6 episodes of syncope! Last episode happened as she stood up from a chair BP 88/62, HR 87 🧠 OK, CRT 2 sec 1/8
16
93
259